Randomized, open-label, perioperative phase II study evaluating nivolumab alone or nivolumab plus ipilimumab in patients with resectable HCC.
Year: 2020
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Ahmed Omar Kaseb, Dan G. Duda, Hop Sanderson Tran Cao, Yehia I. Abugabal, Luis M. Vence, Asif Rashid, Roberto Pestana, Jorge M. Blando, Shalini Singh, Jean-Nicolas Vauthey, Manal Hassan, Hesham M. Amin, Aliya Qayyum, Yun Shin Chun, Ching-Wei David Tzeng, Divya Sakamuri, Robert A. Wolff, James C. Yao, James Patrick Allison, Padmanee Sharma
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2912335683